Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
Noosa News5 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News11 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General10 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News11 hours agoDetectives continue to search for answers on Crystal Beale’s death